The exterior of Thermo Fisher Gibco cell culture media manufacturing facility Grand Island, New York

Tour our facility

Take 360° tours of our Grand Island cell culture media manufacturing facility. Learn about our approach to site-to-site equivalency, or watch our short site introduction video to learn about our harmonized global media manufacturing processes.

Request additional information or learn how to qualify our site for your manufacturing needs.

Schedule facility review

Dry powder media manufacturing expansion completed

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, we have recently expanded our dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space. This includes manufacturing of Thermo Fisher’s Advanced Granulation Technology (AGT) format and other AOF Dry Powder Media (DPM) products.

AGT granulation suite

Fluid bed manufacturing suite Gibco Grand Island advanced granulation technology cell culture media

Doubles the site’s AGT media format manufacturing capacity

Dry powder milling & blending suites

Thermo Fisher expanded dry powder media milling and blending suite Grand Island

Two suites equipped with 75 cu. ft. blenders and FitzMill™ technology

Tumble blender suite

Thermo Fisher tumble blender suite at expanded Grand Island dry powder Gibco manufacturing site

Used for smaller, custom media batches


Self-guided virtual tour

Experience our 360° tour below. Look for informational hotspots along the tour and click them to learn more about equipment seen and the rooms you are visiting.

Watch our facility overview video

Learn about our dry powder media expansion project recently completed in Grand Island to help decrease lead times for our customers.

Site details at a glance

Snapshot:

  • Media, reagents, sera
  • Media and analytical services
  • Pilot labs, Gibco Rapid Prototyping Services
  • ISO 13485, 21 CFR 820
  • FDA registered

Key manufacturing capabilities:

  • Powder manufacturing
    • Dry powder media (DPM)
    • Gibco Advanced Granulation Technology (AGT) media
  • Liquid manufacturing
    • Cell culture media
    • Supplements

Site data:

  • Building size: 307,034 sq. ft.
Related resources

Media Manufacturing Services

With expertise in media manufacturing, scalable solutions and format conversion, learn how we can help enhance your workflows—from non-GMP media prototyping to manufacturing your own formulation.

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: